Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients

MLA

Young Sun Kang, et al. “Plasma Concentration of Visfatin Is a New Surrogate Marker of Systemic Inflammation in Type 2 Diabetic Patients.” Diabetes Research and Clinical Practice, vol. 89, no. 2, Jan. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7710bd7d6ab809cd827d8389a7a1fe2c&authtype=sso&custid=ns315887.

APA

Young Sun Kang, Hye Kyoung Song, Dae Ryong Cha, Mi Hwa Lee, & Gang Jee Ko. (2010). Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients. Diabetes Research and Clinical Practice, 89(2).

Chicago

Young Sun Kang, Hye Kyoung Song, Dae Ryong Cha, Mi Hwa Lee, and Gang Jee Ko. 2010. “Plasma Concentration of Visfatin Is a New Surrogate Marker of Systemic Inflammation in Type 2 Diabetic Patients.” Diabetes Research and Clinical Practice 89 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7710bd7d6ab809cd827d8389a7a1fe2c&authtype=sso&custid=ns315887.